ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $169,000 | -82.8% | 28,005 | -89.7% | 0.00% | -88.9% |
| Q3 2019 | $981,000 | +178.7% | 272,465 | +107.7% | 0.01% | +200.0% |
| Q2 2019 | $352,000 | +186.2% | 131,168 | +216.8% | 0.00% | +200.0% |
| Q1 2019 | $123,000 | +48.2% | 41,407 | -20.9% | 0.00% | 0.0% |
| Q4 2018 | $83,000 | -93.9% | 52,328 | -85.9% | 0.00% | -93.8% |
| Q3 2018 | $1,368,000 | +117.1% | 371,657 | +66.9% | 0.02% | +100.0% |
| Q2 2018 | $630,000 | -5.8% | 222,685 | -4.1% | 0.01% | -33.3% |
| Q4 2017 | $669,000 | +208.3% | 232,146 | +381.1% | 0.01% | +200.0% |
| Q3 2017 | $217,000 | -11.4% | 48,251 | -17.2% | 0.00% | -42.9% |
| Q1 2017 | $245,000 | -61.2% | 58,268 | -61.9% | 0.01% | -73.1% |
| Q4 2016 | $631,000 | +122.2% | 152,825 | +336.6% | 0.03% | +36.8% |
| Q3 2016 | $284,000 | -35.5% | 35,000 | -37.9% | 0.02% | -29.6% |
| Q2 2016 | $440,000 | +95.6% | 56,400 | +93.8% | 0.03% | +58.8% |
| Q1 2016 | $225,000 | -70.5% | 29,100 | -58.9% | 0.02% | -79.8% |
| Q4 2015 | $764,000 | – | 70,800 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |